DSC

Vidipha (VDP) will issue 9.94 million shares to existing shareholders at 10,000 VND/share, raising over 99.3 billion VND to invest in a Cephalosporin injection production line targeting EU-GMP standards. The rights offering, with a 100:45 ratio, will increase charter capital from 220.8 billion VND to 320.2 billion VND. Major shareholders including DSC and DVN are expected to participate.

DSC Securities reported Q1/2026 revenue of VND 184 billion, a 39.4% year-on-year increase, while pre-tax profit rose 7% to VND 72 billion. The company is actively pursuing a co-investment strategy with TC Group to acquire pharmaceutical firms, aiming for full-year revenue of VND 747 billion and targeting a return on equity above 10%.

Capella Group becomes a major shareholder in DNSE Securities (DSE) with a 9.8% stake after acquiring 42.075 million shares through a rights issue that raised VND 1,275 billion. The move signals strategic alignment between Capella and DNSE, with Capella's technology director joining the board. Separately, an individual became a major shareholder in DSC Securities (DSC) via a similar rights offering in November 2025.

DSC Securities targets 2026 pre-tax profit of VND 356B (+3%) and revenue of VND 747B (+7%), both record highs, approved at its 2026 AGM. The plan emphasizes maximizing margin lending profitability and deepening client exploitation from the TC Group ecosystem.